img

Global Sunitinib Malate Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sunitinib Malate Sales Market Report 2024

Market Analysis and InsightsGlobal Sunitinib Malate Market
The demand of sunitinib malate is increasing, and global advancement of technology and increasing prevalence of pancreatic cancer are the prime growth drivers of the global sunitinib malate market.
Due to the COVID-19 pandemic, the global Sunitinib Malate market size is estimated to be worth US$ 49 million in 2024 and is forecast to a readjusted size of US$ 87 million by 2034 with a CAGR of 7.9% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, PurityAbove 99% accounting for % of the Sunitinib Malate global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Pancreatic Neuroendocrine Tumors segment is altered to an % CAGR throughout this forecast period.
The United States Sunitinib Malate market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Sunitinib Malate include Pfizer, Topcarepharm, Njfirstpharm, J&K Scientific and Targetmol, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Sunitinib Malate Scope and Market Size
The global Sunitinib Malate market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Sunitinib Malate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
PurityAbove 99%
PurityAbove 98%
PurityAbove 97%

Segment by Application


Pancreatic Neuroendocrine Tumors
Kidney Cancer
Gastrointestinal stromal tumor
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions



By Company


Pfizer
Topcarepharm
Njfirstpharm
J&K Scientific
Targetmol

Table of Content

1 Sunitinib Malate Market Overview
1.1 Sunitinib Malate Product Scope
1.2 Sunitinib Malate Segment by Type
1.2.1 Global Sunitinib Malate Sales by Type (2018 & 2024 & 2034)
1.2.2 Purity: Above 99%
1.2.3 Purity: Above 98%
1.2.4 Purity: Above 97%
1.3 Sunitinib Malate Segment by Application
1.3.1 Global Sunitinib Malate Sales Comparison by Application (2018 & 2024 & 2034)
1.3.2 Pancreatic Neuroendocrine Tumors
1.3.3 Kidney Cancer
1.3.4 Gastrointestinal stromal tumor
1.3.5 Others
1.4 Sunitinib Malate Market Estimates and Forecasts (2018-2034)
1.4.1 Global Sunitinib Malate Market Size in Value Growth Rate (2018-2034)
1.4.2 Global Sunitinib Malate Market Size in Volume Growth Rate (2018-2034)
1.4.3 Global Sunitinib Malate Price Trends (2018-2034)
2 Sunitinib Malate Estimates and Forecasts by Region
2.1 Global Sunitinib Malate Market Size by Region: 2018 VS 2024 VS 2034
2.2 Global Sunitinib Malate Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Sunitinib Malate Sales Market Share by Region (2018-2023)
2.2.2 Global Sunitinib Malate Revenue Market Share by Region (2018-2023)
2.3 Global Sunitinib Malate Market Estimates and Forecasts by Region (2024-2034)
2.3.1 Global Sunitinib Malate Sales Estimates and Forecasts by Region (2024-2034)
2.3.2 Global Sunitinib Malate Revenue Forecast by Region (2024-2034)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Sunitinib Malate Estimates and Projections (2018-2034)
2.4.2 Europe Sunitinib Malate Estimates and Projections (2018-2034)
2.4.3 China Sunitinib Malate Estimates and Projections (2018-2034)
2.4.4 Japan Sunitinib Malate Estimates and Projections (2018-2034)
2.4.5 Southeast Asia Sunitinib Malate Estimates and Projections (2018-2034)
2.4.6 India Sunitinib Malate Estimates and Projections (2018-2034)
3 Global Sunitinib Malate Competition Landscape by Players
3.1 Global Top Sunitinib Malate Players by Sales (2018-2023)
3.2 Global Top Sunitinib Malate Players by Revenue (2018-2023)
3.3 Global Sunitinib Malate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sunitinib Malate as of 2024)
3.4 Global Sunitinib Malate Average Price by Company (2018-2023)
3.5 Manufacturers Sunitinib Malate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Sunitinib Malate Market Size by Type
4.1 Global Sunitinib Malate Historic Market Review by Type (2018-2023)
4.1.1 Global Sunitinib Malate Sales by Type (2018-2023)
4.1.2 Global Sunitinib Malate Revenue by Type (2018-2023)
4.1.3 Global Sunitinib Malate Price by Type (2018-2023)
4.2 Global Sunitinib Malate Market Estimates and Forecasts by Type (2024-2034)
4.2.1 Global Sunitinib Malate Sales Forecast by Type (2024-2034)
4.2.2 Global Sunitinib Malate Revenue Forecast by Type (2024-2034)
4.2.3 Global Sunitinib Malate Price Forecast by Type (2024-2034)
5 Global Sunitinib Malate Market Size by Application
5.1 Global Sunitinib Malate Historic Market Review by Application (2018-2023)
5.1.1 Global Sunitinib Malate Sales by Application (2018-2023)
5.1.2 Global Sunitinib Malate Revenue by Application (2018-2023)
5.1.3 Global Sunitinib Malate Price by Application (2018-2023)
5.2 Global Sunitinib Malate Market Estimates and Forecasts by Application (2024-2034)
5.2.1 Global Sunitinib Malate Sales Forecast by Application (2024-2034)
5.2.2 Global Sunitinib Malate Revenue Forecast by Application (2024-2034)
5.2.3 Global Sunitinib Malate Price Forecast by Application (2024-2034)
6 United States Sunitinib Malate Market Facts & Figures
6.1 United States Sunitinib Malate Sales by Company
6.1.1 United States Sunitinib Malate Sales by Company (2018-2023)
6.1.2 United States Sunitinib Malate Revenue by Company (2018-2023)
6.2 United States Sunitinib Malate Sales Breakdown by Type
6.2.1 United States Sunitinib Malate Sales Breakdown by Type (2018-2023)
6.2.2 United States Sunitinib Malate Sales Breakdown by Type (2024-2034)
6.3 United States Sunitinib Malate Sales Breakdown by Application
6.3.1 United States Sunitinib Malate Sales Breakdown by Application (2018-2023)
6.3.2 United States Sunitinib Malate Sales Breakdown by Application (2024-2034)
7 Europe Sunitinib Malate Market Facts & Figures
7.1 Europe Sunitinib Malate Sales by Company
7.1.1 Europe Sunitinib Malate Sales by Company (2018-2023)
7.1.2 Europe Sunitinib Malate Revenue by Company (2018-2023)
7.2 Europe Sunitinib Malate Sales Breakdown by Type
7.2.1 Europe Sunitinib Malate Sales Breakdown by Type (2018-2023)
7.2.2 Europe Sunitinib Malate Sales Breakdown by Type (2024-2034)
7.3 Europe Sunitinib Malate Sales Breakdown by Application
7.3.1 Europe Sunitinib Malate Sales Breakdown by Application (2018-2023)
7.3.2 Europe Sunitinib Malate Sales Breakdown by Application (2024-2034)
8 China Sunitinib Malate Market Facts & Figures
8.1 China Sunitinib Malate Sales by Company
8.1.1 China Sunitinib Malate Sales by Company (2018-2023)
8.1.2 China Sunitinib Malate Revenue by Company (2018-2023)
8.2 China Sunitinib Malate Sales Breakdown by Type
8.2.1 China Sunitinib Malate Sales Breakdown by Type (2018-2023)
8.2.2 China Sunitinib Malate Sales Breakdown by Type (2024-2034)
8.3 China Sunitinib Malate Sales Breakdown by Application
8.3.1 China Sunitinib Malate Sales Breakdown by Application (2018-2023)
8.3.2 China Sunitinib Malate Sales Breakdown by Application (2024-2034)
9 Japan Sunitinib Malate Market Facts & Figures
9.1 Japan Sunitinib Malate Sales by Company
9.1.1 Japan Sunitinib Malate Sales by Company (2018-2023)
9.1.2 Japan Sunitinib Malate Revenue by Company (2018-2023)
9.2 Japan Sunitinib Malate Sales Breakdown by Type
9.2.1 Japan Sunitinib Malate Sales Breakdown by Type (2018-2023)
9.2.2 Japan Sunitinib Malate Sales Breakdown by Type (2024-2034)
9.3 Japan Sunitinib Malate Sales Breakdown by Application
9.3.1 Japan Sunitinib Malate Sales Breakdown by Application (2018-2023)
9.3.2 Japan Sunitinib Malate Sales Breakdown by Application (2024-2034)
10 Southeast Asia Sunitinib Malate Market Facts & Figures
10.1 Southeast Asia Sunitinib Malate Sales by Company
10.1.1 Southeast Asia Sunitinib Malate Sales by Company (2018-2023)
10.1.2 Southeast Asia Sunitinib Malate Revenue by Company (2018-2023)
10.2 Southeast Asia Sunitinib Malate Sales Breakdown by Type
10.2.1 Southeast Asia Sunitinib Malate Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Sunitinib Malate Sales Breakdown by Type (2024-2034)
10.3 Southeast Asia Sunitinib Malate Sales Breakdown by Application
10.3.1 Southeast Asia Sunitinib Malate Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Sunitinib Malate Sales Breakdown by Application (2024-2034)
11 India Sunitinib Malate Market Facts & Figures
11.1 India Sunitinib Malate Sales by Company
11.1.1 India Sunitinib Malate Sales by Company (2018-2023)
11.1.2 India Sunitinib Malate Revenue by Company (2018-2023)
11.2 India Sunitinib Malate Sales Breakdown by Type
11.2.1 India Sunitinib Malate Sales Breakdown by Type (2018-2023)
11.2.2 India Sunitinib Malate Sales Breakdown by Type (2024-2034)
11.3 India Sunitinib Malate Sales Breakdown by Application
11.3.1 India Sunitinib Malate Sales Breakdown by Application (2018-2023)
11.3.2 India Sunitinib Malate Sales Breakdown by Application (2024-2034)
12 Company Profiles and Key Figures in Sunitinib Malate Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Sunitinib Malate Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Pfizer Sunitinib Malate Products Offered
12.1.5 Pfizer Recent Development
12.2 Topcarepharm
12.2.1 Topcarepharm Corporation Information
12.2.2 Topcarepharm Business Overview
12.2.3 Topcarepharm Sunitinib Malate Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Topcarepharm Sunitinib Malate Products Offered
12.2.5 Topcarepharm Recent Development
12.3 Njfirstpharm
12.3.1 Njfirstpharm Corporation Information
12.3.2 Njfirstpharm Business Overview
12.3.3 Njfirstpharm Sunitinib Malate Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Njfirstpharm Sunitinib Malate Products Offered
12.3.5 Njfirstpharm Recent Development
12.4 J&K Scientific
12.4.1 J&K Scientific Corporation Information
12.4.2 J&K Scientific Business Overview
12.4.3 J&K Scientific Sunitinib Malate Sales, Revenue and Gross Margin (2018-2023)
12.4.4 J&K Scientific Sunitinib Malate Products Offered
12.4.5 J&K Scientific Recent Development
12.5 Targetmol
12.5.1 Targetmol Corporation Information
12.5.2 Targetmol Business Overview
12.5.3 Targetmol Sunitinib Malate Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Targetmol Sunitinib Malate Products Offered
12.5.5 Targetmol Recent Development
13 Sunitinib Malate Manufacturing Cost Analysis
13.1 Sunitinib Malate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sunitinib Malate
13.4 Sunitinib Malate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sunitinib Malate Distributors List
14.3 Sunitinib Malate Customers
15 Market Dynamics
15.1 Sunitinib Malate Industry Trends
15.2 Sunitinib Malate Market Drivers
15.3 Sunitinib Malate Market Challenges
15.4 Sunitinib Malate Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sunitinib Malate Sales (US$ Million) Growth Rate by Type (2018 & 2024 & 2034)
Table 2. Global Sunitinib Malate Sales ((US$ Million)) Comparison by Application (2018 & 2024 & 2034)
Table 3. Global Sunitinib Malate Market Size (US$ Million) by Region: 2018 VS 2024 VS 2034
Table 4. Global Sunitinib Malate Sales (MT) by Region (2018-2023)
Table 5. Global Sunitinib Malate Sales Market Share by Region (2018-2023)
Table 6. Global Sunitinib Malate Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Sunitinib Malate Revenue Share by Region (2018-2023)
Table 8. Global Sunitinib Malate Sales (MT) Forecast by Region (2024-2034)
Table 9. Global Sunitinib Malate Sales Market Share Forecast by Region (2024-2034)
Table 10. Global Sunitinib Malate Revenue (US$ Million) Forecast by Region (2024-2034)
Table 11. Global Sunitinib Malate Revenue Share Forecast by Region (2024-2034)
Table 12. Global Sunitinib Malate Sales by Company (MT) & (2018-2023)
Table 13. Global Sunitinib Malate Sales Share by Company (2018-2023)
Table 14. Global Sunitinib Malate Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Sunitinib Malate Revenue Share by Company (2018-2023)
Table 16. Global Sunitinib Malate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sunitinib Malate as of 2024)
Table 17. Global Market Sunitinib Malate Average Price by Company (USD/MT) & (2018-2023)
Table 18. Manufacturers Sunitinib Malate Manufacturing Sites and Area Served
Table 19. Manufacturers Sunitinib Malate Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Sunitinib Malate Sales by Type (2018-2023) & (MT)
Table 22. Global Sunitinib Malate Sales Share by Type (2018-2023)
Table 23. Global Sunitinib Malate Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Sunitinib Malate Price by Type (2018-2023) & (USD/MT)
Table 25. Global Sunitinib Malate Sales by Type (2024-2034)
Table 26. Global Sunitinib Malate Revenue by Type (2024-2034) & (US$ Million)
Table 27. Global Sunitinib Malate Revenue Share by Type (2024-2034)
Table 28. Global Sunitinib Malate Price by Type (2024-2034) & (USD/MT)
Table 29. Global Sunitinib Malate Sales by Application (2018-2023) & (MT)
Table 30. Global Sunitinib Malate Sales Share by Application (2018-2023)
Table 31. Global Sunitinib Malate Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Sunitinib Malate Price by Application (2018-2023) & (USD/MT)
Table 33. Global Sunitinib Malate Sales by Application (2024-2034) & (MT)
Table 34. Global Sunitinib Malate Sales Share by Application (2024-2034)
Table 35. Global Sunitinib Malate Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Sunitinib Malate Revenue Share by Application (2024-2034)
Table 37. Global Sunitinib Malate Price by Application (2024-2034) & (USD/MT)
Table 38. United States Sunitinib Malate Sales by Company (2018-2023) & (MT)
Table 39. United States Sunitinib Malate Sales Market Share by Company (2018-2023)
Table 40. United States Sunitinib Malate Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Sunitinib Malate Revenue Market Share by Company (2018-2023)
Table 42. United States Sunitinib Malate Sales by Type (2018-2023) & (MT)
Table 43. United States Sunitinib Malate Sales Market Share by Type (2018-2023)
Table 44. United States Sunitinib Malate Sales by Type (2024-2034) & (MT)
Table 45. United States Sunitinib Malate Sales Market Share by Type (2024-2034)
Table 46. United States Sunitinib Malate Sales by Application (2018-2023) & (MT)
Table 47. United States Sunitinib Malate Sales Market Share by Application (2018-2023)
Table 48. United States Sunitinib Malate Sales by Application (2024-2034) & (MT)
Table 49. United States Sunitinib Malate Sales Market Share by Application (2024-2034)
Table 50. Europe Sunitinib Malate Sales by Company (2018-2023) & (MT)
Table 51. Europe Sunitinib Malate Sales Market Share by Company (2018-2023)
Table 52. Europe Sunitinib Malate Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Sunitinib Malate Revenue Market Share by Company (2018-2023)
Table 54. Europe Sunitinib Malate Sales by Type (2018-2023) & (MT)
Table 55. Europe Sunitinib Malate Sales Market Share by Type (2018-2023)
Table 56. Europe Sunitinib Malate Sales by Type (2024-2034) & (MT)
Table 57. Europe Sunitinib Malate Sales Market Share by Type (2024-2034)
Table 58. Europe Sunitinib Malate Sales by Application (2018-2023) & (MT)
Table 59. Europe Sunitinib Malate Sales Market Share by Application (2018-2023)
Table 60. Europe Sunitinib Malate Sales by Application (2024-2034) & (MT)
Table 61. Europe Sunitinib Malate Sales Market Share by Application (2024-2034)
Table 62. China Sunitinib Malate Sales by Company (2018-2023) & (MT)
Table 63. China Sunitinib Malate Sales Market Share by Company (2018-2023)
Table 64. China Sunitinib Malate Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Sunitinib Malate Revenue Market Share by Company (2018-2023)
Table 66. China Sunitinib Malate Sales by Type (2018-2023) & (MT)
Table 67. China Sunitinib Malate Sales Market Share by Type (2018-2023)
Table 68. China Sunitinib Malate Sales by Type (2024-2034) & (MT)
Table 69. China Sunitinib Malate Sales Market Share by Type (2024-2034)
Table 70. China Sunitinib Malate Sales by Application (2018-2023) & (MT)
Table 71. China Sunitinib Malate Sales Market Share by Application (2018-2023)
Table 72. China Sunitinib Malate Sales by Application (2024-2034) & (MT)
Table 73. China Sunitinib Malate Sales Market Share by Application (2024-2034)
Table 74. Japan Sunitinib Malate Sales by Company (2018-2023) & (MT)
Table 75. Japan Sunitinib Malate Sales Market Share by Company (2018-2023)
Table 76. Japan Sunitinib Malate Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Sunitinib Malate Revenue Market Share by Company (2018-2023)
Table 78. Japan Sunitinib Malate Sales by Type (2018-2023) & (MT)
Table 79. Japan Sunitinib Malate Sales Market Share by Type (2018-2023)
Table 80. Japan Sunitinib Malate Sales by Type (2024-2034) & (MT)
Table 81. Japan Sunitinib Malate Sales Market Share by Type (2024-2034)
Table 82. Japan Sunitinib Malate Sales by Application (2018-2023) & (MT)
Table 83. Japan Sunitinib Malate Sales Market Share by Application (2018-2023)
Table 84. Japan Sunitinib Malate Sales by Application (2024-2034) & (MT)
Table 85. Japan Sunitinib Malate Sales Market Share by Application (2024-2034)
Table 86. Southeast Asia Sunitinib Malate Sales by Company (2018-2023) & (MT)
Table 87. Southeast Asia Sunitinib Malate Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Sunitinib Malate Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Sunitinib Malate Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Sunitinib Malate Sales by Type (2018-2023) & (MT)
Table 91. Southeast Asia Sunitinib Malate Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Sunitinib Malate Sales by Type (2024-2034) & (MT)
Table 93. Southeast Asia Sunitinib Malate Sales Market Share by Type (2024-2034)
Table 94. Southeast Asia Sunitinib Malate Sales by Application (2018-2023) & (MT)
Table 95. Southeast Asia Sunitinib Malate Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Sunitinib Malate Sales by Application (2024-2034) & (MT)
Table 97. Southeast Asia Sunitinib Malate Sales Market Share by Application (2024-2034)
Table 98. India Sunitinib Malate Sales by Company (2018-2023) & (MT)
Table 99. India Sunitinib Malate Sales Market Share by Company (2018-2023)
Table 100. India Sunitinib Malate Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Sunitinib Malate Revenue Market Share by Company (2018-2023)
Table 102. India Sunitinib Malate Sales by Type (2018-2023) & (MT)
Table 103. India Sunitinib Malate Sales Market Share by Type (2018-2023)
Table 104. India Sunitinib Malate Sales by Type (2024-2034) & (MT)
Table 105. India Sunitinib Malate Sales Market Share by Type (2024-2034)
Table 106. India Sunitinib Malate Sales by Application (2018-2023) & (MT)
Table 107. India Sunitinib Malate Sales Market Share by Application (2018-2023)
Table 108. India Sunitinib Malate Sales by Application (2024-2034) & (MT)
Table 109. India Sunitinib Malate Sales Market Share by Application (2024-2034)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Sunitinib Malate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Pfizer Sunitinib Malate Product
Table 114. Pfizer Recent Development
Table 115. Topcarepharm Corporation Information
Table 116. Topcarepharm Description and Business Overview
Table 117. Topcarepharm Sunitinib Malate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Topcarepharm Sunitinib Malate Product
Table 119. Topcarepharm Recent Development
Table 120. Njfirstpharm Corporation Information
Table 121. Njfirstpharm Description and Business Overview
Table 122. Njfirstpharm Sunitinib Malate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Njfirstpharm Sunitinib Malate Product
Table 124. Njfirstpharm Recent Development
Table 125. J&K Scientific Corporation Information
Table 126. J&K Scientific Description and Business Overview
Table 127. J&K Scientific Sunitinib Malate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. J&K Scientific Sunitinib Malate Product
Table 129. J&K Scientific Recent Development
Table 130. Targetmol Corporation Information
Table 131. Targetmol Description and Business Overview
Table 132. Targetmol Sunitinib Malate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Targetmol Sunitinib Malate Product
Table 134. Targetmol Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Sunitinib Malate Distributors List
Table 138. Sunitinib Malate Customers List
Table 139. Sunitinib Malate Market Trends
Table 140. Sunitinib Malate Market Drivers
Table 141. Sunitinib Malate Market Challenges
Table 142. Sunitinib Malate Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Sunitinib Malate Product Picture
Figure 2. Global Sunitinib Malate Sales (US$ Million) by Type (2018 & 2024 & 2034)
Figure 3. Global Sunitinib Malate Sales Market Share by Type in 2024 & 2034
Figure 4. Purity: Above 99% Product Picture
Figure 5. Purity: Above 98% Product Picture
Figure 6. Purity: Above 97% Product Picture
Figure 7. Global Sunitinib Malate Sales (US$ Million) by Application (2018 & 2024 & 2034)
Figure 8. Global Sunitinib Malate Sales Market Share by Application in 2024 & 2034
Figure 9. Pancreatic Neuroendocrine Tumors Examples
Figure 10. Kidney Cancer Examples
Figure 11. Gastrointestinal stromal tumor Examples
Figure 12. Others Examples
Figure 13. Global Sunitinib Malate Sales, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Sunitinib Malate Sales Growth Rate (2018-2034) & (US$ Million)
Figure 15. Global Sunitinib Malate Sales (MT) Growth Rate (2018-2034)
Figure 16. Global Sunitinib Malate Price Trends Growth Rate (2018-2034) & (USD/MT)
Figure 17. Global Market Sunitinib Malate Market Size (US$ Million) by Region:2018 VS 2024 VS 2034
Figure 18. Global Sunitinib Malate Revenue Market Share by Region: 2018 VS 2024
Figure 19. United States Sunitinib Malate Revenue (US$ Million) Growth Rate (2018-2034)
Figure 20. United States Sunitinib Malate Sales (MT) Growth Rate (2018-2034)
Figure 21. Europe Sunitinib Malate Revenue (US$ Million) Growth Rate (2018-2034)
Figure 22. Europe Sunitinib Malate Sales (US$ Million) Growth Rate (2018-2034)
Figure 23. China Sunitinib Malate Revenue (US$ Million) Growth Rate (2018-2034)
Figure 24. China Sunitinib Malate Sales (US$ Million) and Growth Rate (2018-2034)
Figure 25. Japan Sunitinib Malate Revenue (US$ Million) Growth Rate (2018-2034)
Figure 26. Japan Sunitinib Malate Sales (US$ Million) Growth Rate (2018-2034)
Figure 27. Southeast Asia Sunitinib Malate Revenue (US$ Million) Growth Rate (2018-2034)
Figure 28. Southeast Asia Sunitinib Malate Sales (US$ Million) Growth Rate (2018-2034)
Figure 29. India Sunitinib Malate Revenue (US$ Million) Growth Rate (2018-2034)
Figure 30. India Sunitinib Malate Sales (US$ Million) Growth Rate (2018-2034)
Figure 31. Global 5 Largest Sunitinib Malate Players Market Share by Revenue in Sunitinib Malate: 2018 & 2024
Figure 32. Sunitinib Malate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 33. Global Sunitinib Malate Revenue Share by Type (2018-2023)
Figure 34. Global Sunitinib Malate Sales Share by Type (2024-2034)
Figure 35. Global Sunitinib Malate Revenue Share by Type (2024-2034)
Figure 36. Global Sunitinib Malate Revenue Share by Application (2018-2023)
Figure 37. Global Sunitinib Malate Revenue Growth Rate by Application in 2018 & 2024
Figure 38. Global Sunitinib Malate Sales Share by Application (2024-2034)
Figure 39. Global Sunitinib Malate Revenue Share by Application (2024-2034)
Figure 40. Key Raw Materials Price Trend
Figure 41. Manufacturing Cost Structure of Sunitinib Malate
Figure 42. Manufacturing Process Analysis of Sunitinib Malate
Figure 43. Sunitinib Malate Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed